Journal
NEUROPHARMACOLOGY
Volume 134, Issue -, Pages 240-248Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2017.09.033
Keywords
Intracerebral hemorrhage; Thrombin; Iron; Brain edema; Hypertension; Hematoma
Categories
Funding
- National Institutes of Health (NIH) [NS-007222, NS-073959, NS-079157, NS-090925, NS-091545, NS-093399, NS-096917]
Ask authors/readers for more resources
Intracerebral hemorrhage (ICH) is the most common hemorrhagic stroke subtype, and rates are increasing with an aging population. Despite an increase in research and trials of therapies for ICH, mortality remains high and no interventional therapy has been demonstrated to improve outcomes. We review known mechanisms of injury, recent clinical trial results, and newly discovered signaling pathways involved in hematoma clearance. Enthusiasm remains high for methods of minimally invasive clot removal as well as pharmacologic strategies to improve recovery after ICH, both of which are currently being evaluated in clinical trials. This article is part of the Special Issue entitled 'Cerebral lschemia'. (C) 2017 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available